Objective:

This study aims to identify the prevalence of aspirin use among type 2 diabetic (T2DM) patients and assess the concordance in aspirin use among these patients as prescribed by physicians and as recommended by the Aspirin-Guide app.

Methods:

A total of 301 T2DM patients from King Khalid University Hospital in Riyadh, Saudi Arabia participated in this cross-sectional study. Patient’s electronic medical records through eSihi system were reviewed and all data included in the free online and mobile app called Aspirin-Guide were collected in a specially designed data checklist.

Result:

The prevalence of aspirin use was more common in patients who were in the age group of 51 to 59 and male participants’ with T2DM. Males were nearly twice more likely to use aspirin compared to females (p = 0.001). Based on recommendations from the Aspirin-Guide app, 26% of the patients who were on aspirin (N = 51) were not eligible for aspirin therapy, while 37.7% (N = 40) of the patients eligible for aspirin therapy had not been put on aspirin by their physicians (p = 0.039). Male sex (P = 0.003), use of statins (P = 0.001), and being advised to use aspirin (P = 0.041), were significantly associated with aspirin use in T2DM patients.

Conclusion:

There was a significant difference in the proportion of patients currently on aspirin as prescribed by their physicians and those eligible for aspirin therapy as per the Aspirin-Guide app. The use of an app to uniformized aspirin use among eligible patients should be based on up-to-date guidelines and account for patient acceptability and willingness to commence treatment.

中文翻译：

---

Aspirin-Guide App 的推荐和医师使用阿司匹林预防糖尿病患者 CVD 的临床决策，有什么不同吗？

客观的：

本研究旨在确定 2 型糖尿病 (T2DM) 患者中阿司匹林使用的流行率，并评估这些患者中阿司匹林使用情况的一致性，这些患者按照医生的规定和 Aspirin-Guide 应用程序的建议使用。

方法：

来自沙特阿拉伯利雅得哈立德国王大学医院的 301 名 T2DM 患者参与了这项横断面研究。通过 eSihi 系统审查了患者的电子病历，并在名为 Aspirin-Guide 的免费在线和移动应用程序中收集了所有数据，并将其收集在专门设计的数据清单中。

结果：

阿司匹林的使用率在 51 至 59 岁的患者和患有 T2DM 的男性参与者中更为常见。与女性相比，男性使用阿司匹林的可能性几乎是女性的两倍（p = 0.001）。根据 Aspirin-Guide 应用程序的建议，26% 的服用阿司匹林的患者 (N = 51) 不符合阿司匹林治疗的条件，而符合阿司匹林治疗条件的患者中有 37.7% (N = 40) 没有接受阿司匹林治疗他们的医生服用阿司匹林 (p = 0.039)。男性（P = 0.003）、使用他汀类药物（P = 0.001）和被建议使用阿司匹林（P = 0.041）与 T2DM 患者使用阿司匹林显着相关。

结论：

目前按照医生处方服用阿司匹林的患者比例与根据 Aspirin-Guide 应用程序符合阿司匹林治疗条件的患者比例存在显着差异。在符合条件的患者中使用应用程序统一阿司匹林的使用应基于最新的指南，并考虑患者的可接受性和开始治疗的意愿。